Published in Biochemistry on May 16, 1989
Highly specific and broadly potent inhibitors of mammalian secreted phospholipases A2. J Med Chem (2008) 1.49
Characterization of a novel inhibitor of cytosolic phospholipase A2alpha, pyrrophenone. Biochem J (2002) 1.11
Assay of phospholipases A(2) and their inhibitors by kinetic analysis in the scooting mode. Mediators Inflamm (1992) 1.03
Biochemical characterization of selective inhibitors of human group IIA secreted phospholipase A(2) and hyaluronic acid-linked inhibitor conjugates. Biochemistry (2012) 0.82
Cysteine-less glycosylphosphatidylinositol-specific phospholipase C is inhibited competitively by a thiol reagent: evidence for glyco-mimicry by p-chloromercuriphenylsulphonate. Biochem J (2002) 0.77
Complete Tetrasaccharide Repeat Unit Biosynthesis of the Immunomodulatory Bacteroides fragilis Capsular Polysaccharide A. ACS Chem Biol (2016) 0.75
Inhibitory effect of metalloporphyrins in conjunction with cholesterol on hepatic phospholipase A(2) activityin vivo in rats. Indian J Clin Biochem (2000) 0.75
How is the level of free arachidonic acid controlled in mammalian cells? Biochem J (1982) 3.96
Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids. J Biol Chem (1987) 2.75
Histidine at the active site of phospholipase A2. Biochemistry (1974) 2.34
Action of phospholipase A at interfaces. J Biol Chem (1973) 1.70
The kinetics of interfacial catalysis by phospholipase A2 and regulation of interfacial activation: hopping versus scooting. Biochim Biophys Acta (1989) 1.62
Chemical and biochemical aspects of platelet activating factor: a novel class of acetylated ether-linked choline-phospholipids. Med Res Rev (1985) 1.32
Characterization of three edema-inducing phospholipase A2 enzymes from habu (Trimeresurus flavoviridis) venom and their interaction with the alkaloid aristolochic acid. Toxicon (1987) 1.20
Studies on the arachidonic acid cascade--I. Inhibition of phospholipase A2 in vitro and in vivo by several novel series of inhibitor compounds. Biochem Pharmacol (1981) 1.13
Potential therapeutic efficacy of inhibitors of human phospholipase A2 in septic shock. Agents Actions (1986) 1.11
Affinity chromatography of phospholipase A2 from Naja naja naja (Indian cobra) venom. Toxicon (1985) 0.93
Kinetics of interfacial catalysis by phospholipase A2 in intravesicle scooting mode, and heterofusion of anionic and zwitterionic vesicles. Biochim Biophys Acta (1986) 0.91
Action of phospholipase A2 on bilayers. Effect of inhibitors. Biochim Biophys Acta (1985) 0.91
Action of phospholipase A2 on bilayers containing lysophosphatidylcholine analogs and the effect of inhibitors. Biochem Pharmacol (1984) 0.88
Anchoring of phospholipase A2: the effect of anions and deuterated water, and the role of N-terminus region. Biochim Biophys Acta (1986) 0.87
Kinetics of binding of phospholipase A2 to lipid/water interfaces and its relationship to interfacial activation. Biochim Biophys Acta (1988) 0.84
The isolation and characterization of a third or neutral phospholipase A2 in the venom of Agkistrodon halys blomhoffii. An improved fractionation procedure for all three enzymes. Biochim Biophys Acta (1980) 0.81
Phospholipases. III. Effects of ionic surfactants on the phospholipase-catalyzed hydrolysis of unsonicated egg lecithin liposomes. J Membr Biol (1975) 0.80
Involvement of chemokine receptors in breast cancer metastasis. Nature (2001) 26.07
Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol (1999) 21.92
Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. Circ Res (2001) 5.08
Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol Microbiol (1996) 4.86
mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob Agents Chemother (1997) 4.38
Fractional SR Ca release is regulated by trigger Ca and SR Ca content in cardiac myocytes. Am J Physiol (1995) 4.15
Upregulation of Na(+)/Ca(2+) exchanger expression and function in an arrhythmogenic rabbit model of heart failure. Circ Res (1999) 3.35
Conversion of diploidy to haploidy. Nature (2000) 3.28
Prenyl proteins in eukaryotic cells: a new type of membrane anchor. Trends Biochem Sci (1990) 3.12
Interfacial catalysis: the mechanism of phospholipase A2. Science (1990) 2.84
Dentinogenesis imperfecta 1 with or without progressive hearing loss is associated with distinct mutations in DSPP. Nat Genet (2001) 2.75
Human lamin B contains a farnesylated cysteine residue. J Biol Chem (1989) 2.71
Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group. Neurology (2000) 2.64
Vertebrate slit, a secreted ligand for the transmembrane protein roundabout, is a repellent for olfactory bulb axons. Cell (1999) 2.35
Brain G protein gamma subunits contain an all-trans-geranylgeranylcysteine methyl ester at their carboxyl termini. Proc Natl Acad Sci U S A (1990) 2.26
Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: involvement of Smad 3. J Invest Dermatol (1999) 2.20
PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J Control Release (2001) 2.15
Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2. Biochemistry (1993) 1.93
Identification of geranylgeranyl-modified proteins in HeLa cells. Science (1990) 1.88
Occupational exposure to bisphenol-A (BPA) and the risk of self-reported male sexual dysfunction. Hum Reprod (2009) 1.87
Protein geranylgeranyltransferase of Saccharomyces cerevisiae is specific for Cys-Xaa-Xaa-Leu motif proteins and requires the CDC43 gene product but not the DPR1 gene product. Proc Natl Acad Sci U S A (1991) 1.83
Preferential release of 11-cis-retinol from retinal pigment epithelial cells in the presence of cellular retinaldehyde-binding protein. J Biol Chem (1999) 1.81
Crystal structure of cobra-venom phospholipase A2 in a complex with a transition-state analogue. Science (1990) 1.77
Interfacial enzymology: the secreted phospholipase A(2)-paradigm. Chem Rev (2001) 1.71
C terminus of the small GTP-binding protein smg p25A contains two geranylgeranylated cysteine residues and a methyl ester. Proc Natl Acad Sci U S A (1991) 1.69
Crystal structure of bee-venom phospholipase A2 in a complex with a transition-state analogue. Science (1990) 1.65
A protein geranylgeranyltransferase from bovine brain: implications for protein prenylation specificity. Proc Natl Acad Sci U S A (1991) 1.65
Translocation of the 85-kDa phospholipase A2 from cytosol to the nuclear envelope in rat basophilic leukemia cells stimulated with calcium ionophore or IgE/antigen. J Biol Chem (1995) 1.65
1,25-Dihydroxyvitamin D3 targeting of NF-kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells. Kidney Int (2007) 1.64
Shanghai premarital adolescent use of contraceptive methods and analysis of influencing factors. Chin J Popul Sci (1997) 1.64
Posttranslationally processed structure of the human platelet protein smg p21B: evidence for geranylgeranylation and carboxyl methylation of the C-terminal cysteine. Proc Natl Acad Sci U S A (1990) 1.62
Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of age. Cochrane Database Syst Rev (2008) 1.60
Cloning and characterization of a novel macrolide efflux gene, mreA, from Streptococcus agalactiae. Antimicrob Agents Chemother (1997) 1.59
Mutants of Saccharomyces cerevisiae defective in the farnesylation of Ras proteins. Proc Natl Acad Sci U S A (1990) 1.58
Antagonistic regulation of type I collagen gene expression by interferon-gamma and transforming growth factor-beta. Integration at the level of p300/CBP transcriptional coactivators. J Biol Chem (2000) 1.55
Ca(2+) influx through Ca(2+) channels in rabbit ventricular myocytes during action potential clamp: influence of temperature. Circ Res (1999) 1.52
Type I error in sample size re-estimations based on observed treatment difference. Stat Med (2001) 1.50
Os odontoideum: etiology, diagnosis, and management. Surg Neurol (2000) 1.48
Glycolysis as a target for the design of new anti-trypanosome drugs. Drug Resist Updat (2001) 1.45
Binding of prenylated and polybasic peptides to membranes: affinities and intervesicle exchange. Biochemistry (1995) 1.44
Membrane-binding domain of the small G protein G25K contains an S-(all-trans-geranylgeranyl)cysteine methyl ester at its carboxyl terminus. Proc Natl Acad Sci U S A (1991) 1.43
Serine 727 phosphorylation and activation of cytosolic phospholipase A2 by MNK1-related protein kinases. J Biol Chem (2000) 1.43
Exogenously added human group X secreted phospholipase A(2) but not the group IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cells. J Biol Chem (2000) 1.39
Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta. J Cell Physiol (2000) 1.36
Cytoplasmic trafficking of the canine parvovirus capsid and its role in infection and nuclear transport. J Virol (2000) 1.34
Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations. Neurology (2007) 1.33
Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate. Science (1991) 1.31
Tight binding inhibitors of 85-kDa phospholipase A2 but not 14-kDa phospholipase A2 inhibit release of free arachidonate in thrombin-stimulated human platelets. J Biol Chem (1994) 1.29
Novel human secreted phospholipase A(2) with homology to the group III bee venom enzyme. J Biol Chem (2000) 1.29
A pyrrolidine-based specific inhibitor of cytosolic phospholipase A(2)alpha blocks arachidonic acid release in a variety of mammalian cells. Biochim Biophys Acta (2001) 1.28
Differential prenyl pyrophosphate binding to mammalian protein geranylgeranyltransferase-I and protein farnesyltransferase and its consequence on the specificity of protein prenylation. J Biol Chem (1997) 1.23
Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model. Clin Pharmacol Ther (1999) 1.22
Mechanistic studies on class I polyhydroxybutyrate (PHB) synthase from Ralstonia eutropha: class I and III synthases share a similar catalytic mechanism. Biochemistry (2001) 1.21
Rab geranylgeranyl transferase catalyzes the geranylgeranylation of adjacent cysteines in the small GTPases Rab1A, Rab3A, and Rab5A. Proc Natl Acad Sci U S A (1994) 1.20
Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators. Oncogene (2000) 1.19
Semi-automated color segmentation of anatomical tissue. Comput Med Imaging Graph (2000) 1.18
Interfacial membrane docking of cytosolic phospholipase A2 C2 domain using electrostatic potential-modulated spin relaxation magnetic resonance. Proc Natl Acad Sci U S A (1999) 1.18
PTEN deletion prevents ischemic brain injury by activating the mTOR signaling pathway. Biochem Biophys Res Commun (2010) 1.17
Crystallographic analysis of transition state mimics bound to penicillopepsin: difluorostatine- and difluorostatone-containing peptides. Biochemistry (1992) 1.16
Mapping ligand binding domains in chimeric fibroblast growth factor receptor molecules. Multiple regions determine ligand binding specificity. J Biol Chem (1999) 1.14
Nonstructural protein-2 and the replication of canine parvovirus. Virology (1998) 1.13
On the diversity of secreted phospholipases A(2). Cloning, tissue distribution, and functional expression of two novel mouse group II enzymes. J Biol Chem (1999) 1.12
Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase. Proc Natl Acad Sci U S A (1999) 1.12
The N-terminal domain of p73 interacts with the CH1 domain of p300/CREB binding protein and mediates transcriptional activation and apoptosis. Mol Cell Biol (2000) 1.12
Identification of distinct subpopulations of intercalated cells in the mouse collecting duct. J Am Soc Nephrol (1996) 1.11
Identification of phosphorylation sites of human 85-kDa cytosolic phospholipase A2 expressed in insect cells and present in human monocytes. J Biol Chem (1996) 1.10
Roles of Trp31 in high membrane binding and proinflammatory activity of human group V phospholipase A2. J Biol Chem (1999) 1.10
Fluoro ketone inhibitors of hydrolytic enzymes. Biochemistry (1985) 1.10
The effects of protein farnesyltransferase inhibitors on trypanosomatids: inhibition of protein farnesylation and cell growth. Mol Biochem Parasitol (1998) 1.09
Calcium-dependent and -independent interfacial binding and catalysis of cytosolic group IV phospholipase A2. Biochemistry (1998) 1.08
Palmitoylation of Ha-Ras facilitates membrane binding, activation of downstream effectors, and meiotic maturation in Xenopus oocytes. J Biol Chem (1996) 1.08
Direct profiling of multiple enzyme activities in human cell lysates by affinity chromatography/electrospray ionization mass spectrometry: application to clinical enzymology. Anal Chem (2001) 1.07
Processive interfacial catalysis by mammalian 85-kilodalton phospholipase A2 enzymes on product-containing vesicles: application to the determination of substrate preferences. Biochemistry (1993) 1.07
Identification of the phosphorylation sites of cytosolic phospholipase A2 in agonist-stimulated human platelets and HeLa cells. J Biol Chem (1998) 1.06
Purification of a protein palmitoyltransferase that acts on H-Ras protein and on a C-terminal N-Ras peptide. J Biol Chem (1996) 1.06
Mammalian protein geranylgeranyltransferase-I: substrate specificity, kinetic mechanism, metal requirements, and affinity labeling. Biochemistry (1995) 1.06
Cryphonectria hypovirus 3, a virus species in the family hypoviridae with a single open reading frame. Virology (1999) 1.04
Radiculopathy after laminectomy for cervical compression myelopathy. J Bone Joint Surg Br (1998) 1.04
Binding of the delta subunit to rod phosphodiesterase catalytic subunits requires methylated, prenylated C-termini of the catalytic subunits. Biochemistry (2000) 1.04
Assay of phospholipases A(2) and their inhibitors by kinetic analysis in the scooting mode. Mediators Inflamm (1992) 1.03
Downregulation of microRNA-142 by proto-oncogene LMO2 and its co-factors. Leukemia (2007) 1.01
Bacterial N-succinyl-L-diaminopimelic acid desuccinylase. Purification, partial characterization, and substrate specificity. J Biol Chem (1988) 1.01
Docking phospholipase A2 on membranes using electrostatic potential-modulated spin relaxation magnetic resonance. Science (1998) 1.01
Cardiac myocyte volume, Ca2+ fluxes, and sarcoplasmic reticulum loading in pressure-overload hypertrophy. Am J Physiol (1997) 1.00
Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis. Bone (1996) 1.00
Trifluoromethyl ketones and methyl fluorophosphonates as inhibitors of group IV and VI phospholipases A(2): structure-function studies with vesicle, micelle, and membrane assays. Biochim Biophys Acta (1999) 1.00
A link between catalytic activity, IgE-independent mast cell activation, and allergenicity of bee venom phospholipase A2. J Immunol (1995) 1.00
Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design. J Med Chem (2001) 1.00
Functional interaction of calcium-/calmodulin-dependent protein kinase II and cytosolic phospholipase A(2). J Biol Chem (2001) 0.99
Peptidomimetic inhibitors of protein farnesyltransferase show potent antimalarial activity. Bioorg Med Chem Lett (2001) 0.99
Geranylgeranylated proteins. Biochem Soc Trans (1992) 0.99
High-level expression in Escherichia coli and rapid purification of enzymatically active honey bee venom phospholipase A2. Biochim Biophys Acta (1992) 0.98
Kinetic basis for interfacial catalysis by phospholipase A2. Methods Enzymol (1995) 0.97
Direct repair of defect in lumbar spondylolysis and mild isthmic spondylolisthesis by bone grafting, with or without facet joint fusion. Eur Spine J (2001) 0.97
Stereochemistry and deuterium isotope effects in camphor hydroxylation by the cytochrome P450cam monoxygenase system. Biochemistry (1982) 0.97
Protein prenyltransferases. Biochem Soc Trans (1992) 0.97
Regulation of the cloned L-type cardiac calcium channel by cyclic-AMP-dependent protein kinase. FEBS Lett (1994) 0.97